Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Forma Therapeutics to Participate in Upcoming Investor Conferences


Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that company management will participate in two upcoming investor conferences:

- The Oppenheimer Fall Healthcare Life Sciences & MedTech Summit taking place Sept. 20-23, 2021. Forma will present on Sept. 22, 2021 at 12:25 p.m. Eastern Time.

- The Cantor Global Healthcare Conference taking place Sept. 27-30, 2021. Forma will present on Sept. 27, 2021 at 10:40 a.m. Eastern Time.

Webcast and audio recording of the conference presentations will be available in the "News & Investors" section of Forma's website at www.FormaTherapeutics.com.

About Forma Therapeutics

Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. For more information, please visit www.FormaTherapeutics.com or follow us on Twitter @FORMAInc and LinkedIn.


These press releases may also interest you

at 11:50
Medincell Enters Into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies
Medincell (Paris:MEDCL) today announced a collaboration with AbbVie to co-develop and commercialize up to six therapeutic products across multiple therapeutic areas and indications. Medincell will use its commercial-stage long-acting injectable...

at 11:30
HospiceChoice Rx Welcomes Tracy Page as the Hospice Pharmacy Benefit Innovators Grow Their Reach to New Markets
HospiceChoice Rx is pleased to announce the recent hire of Tracy Page as Sales Director.  Based in the greater Houston area, Ms. Page brings a wealth of healthcare-related experience from her 25-year career, including senior roles as a Business...

at 11:30
/R E P E A T -- Héma-Québec announces partnership with three hospitals to optimize procurement for human tissue donations/
Héma-Québec is proud to announce a new partnership with CIUSSS de l'Estrie?CHUS, CIUSSS de la Mauricie-et-du-Centre-du-Québec and CHU de Québec?Université Laval that will provide the institutions with a local point person specially dedicated to human...

at 11:26
Local Infusion Enters the Connecticut Market, Opens Infusion Center in Rocky Hill, the Sixth Location to Open in New England
Local Infusion, a technology-driven provider for patients with chronic autoimmune diseases on specialty infusion therapy, announced the opening of a state-of-the-art infusion center in Rocky Hill, Connecticut. When patients have a better experience,...

at 11:20
Med First Primary & Urgent Care Continues Growth Across the Carolinas and Shows No Signs of Slowing
Med First Primary & Urgent Care (Med First), an independent primary care group, recently announced that FamHealth Primary Care, located on Creedmoor Rd. in Raleigh, has joined the group, bringing the total number of...

at 11:19
National Analysis Reveals Growing Adolescent Behavioral Health Crisis and Ripple Effects
The toll of the adolescent behavioral health crisis in the United States is vast and growing; varies in prevalence by location, race, sex, and sexual orientation; and has ripple effects on lifetime medical costs, productivity, and wages, according to...

More news about Health...


News published on and distributed by: